Acarix AB (OSTO:ACARIX) 3-Year EBITDA Growth Rate : 25.90% (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Acarix AB 3-Year EBITDA Growth Rate?

Acarix AB's EBITDA per Share for the three months ended in Mar. 2024 was kr-0.02.

During the past 3 years, the average EBITDA Per Share Growth Rate was 25.90% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 34.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 10 years, the highest 3-Year average EBITDA Per Share Growth Rate of Acarix AB was 39.50% per year. The lowest was -22.00% per year. And the median was 12.40% per year.

Competitive Comparison of Acarix AB's 3-Year EBITDA Growth Rate

For the Medical Devices subindustry, Acarix AB's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Acarix AB's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Acarix AB's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Acarix AB's 3-Year EBITDA Growth Rate falls into.

Acarix AB 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Acarix AB (OSTO:ACARIX) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Acarix AB 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Acarix AB's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Acarix AB (OSTO:ACARIX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Acarix AB (OSTO:ACARIX) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

ACIXF:USA 7AC:Germany

Address

World Trade Center Malmo, Jungmansgatan 12, Malmo, SWE, 211 19

Website

https://www.acarix.com

Acarix AB is a Swedish medical technology company that develops innovative solutions for rapid AI-based exclusion of coronary artery disease (CAD). The CE-marked CADScor System, which has also received DeNovo approval from the FDA, is intended for patients experiencing chest pain with suspected coronary artery disease and is designed to help reduce millions of cases of unnecessary, invasive, and costly diagnostics. The CADScor System uses advanced acoustics and AI technology to non-invasively rule out CAD in less than 10 minutes, with at least 96% certainty.

Acarix AB (OSTO:ACARIX) Headlines

No Headlines